Chemoinformaics analysis of Oxacycloheptadec-8-en-2-one
| Molecular Weight | 252.398 | nRot | 0 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 18 |
| Exact Molecular Weight | 252.209 | nRing | 1 |
| Solubility: LogS | -5.897 | nHRing | 1 |
| Solubility: LogP | 6.029 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 46.9942 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.458 |
| Synth | 2.744 |
| Natural Product Likeliness | 0.672 |
| NR-PPAR-gamma | 0.304 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.022 |
| HIA | 0.004 |
| CACO-2 | -4.733 |
| MDCK | 0.000027 |
| BBB | 0.22 |
| PPB | 0.968474 |
| VDSS | 1.745 |
| FU | 0.023858 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.176 |
| CYP2c19-inh | 0.637 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.482 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.1 |
| CYP2d6-sub | 0.139 |
| CYP3a4-inh | 0.497 |
| CYP3a4-sub | 0.071 |
| CL | 8.218 |
| T12 | 0.39 |
| hERG | 0.228 |
| Ames | 0.008 |
| ROA | 0.025 |
| SkinSen | 0.97 |
| Carcinogencity | 0.363 |
| EI | 0.976 |
| Respiratory | 0.654 |
| NR-Aromatase | 0.214 |
| Antiviral | Yes |
| Prediction | 0.734534 |